This company has shut down. AmplifyBio is no longer operating — its last tracked round was a Venture - Series Unknown in 2023.
Explore the Startup GraveyardAmplifyBio is a biotechnology company that develops and advances treatments and cures for disease via cutting-edge technology and research.
AmplifyBio has raised $49.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
AmplifyBio's investors include Narya Capital, Hercules Capital, Battelle, Viking Capital.
AmplifyBio is headquartered in West Jefferson, United States.
AmplifyBio is a biotechnology company that develops and advances treatments and cures for disease via cutting-edge technology and research.
AmplifyBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AmplifyBio — Funding & Investors." VCBacked, November 15, 2023, https://www.vcbacked.co/company/amplifybio. Accessed August 16, 2026.
VCBacked. (2023). AmplifyBio — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/amplifybio
{{cite web |title=AmplifyBio — Funding & Investors |url=https://www.vcbacked.co/company/amplifybio |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated